ライフサイエンスコーパス: Denmark

1 ified at hospital liver clinics (in Southern Denmark).

2 2000-2009, in Lombardia, Northern Italy, and Denmark.

3 the Psychiatric Central Research Register in Denmark.

4 diation levels and one control study site in Denmark.

5 1 102 women) aged 15-94 years were living in Denmark.

6 gnancy and spontaneous loss for all women in Denmark.

7 orders extended across the Atlantic Ocean to Denmark.

8 ence of treatment-demanding ROP over time in Denmark.

9 a A(H10N7) virus, was reported in Sweden and Denmark.

10 Participants: Register-based cohort study in Denmark.

11 ttacks on mental disorders in the Kingdom of Denmark.

12 en maternal age and SCZ risk in offspring in Denmark.

13 22,590 patients underwent DES-PCI in western Denmark.

14 g from Frederiksberg Kommune, Frederiksberg, Denmark.

15 ng: All transfusion recipients in Sweden and Denmark.

16 logy, Zealand University Hospital, Roskilde, Denmark.

17 rant from Health Sciences, Capital Region of Denmark.

18 at the Eye Pathology Institute, Copenhagen, Denmark.

19 Control, Statens Serum Institut, Copenhagen, Denmark.

20 , Greece, Japan, Singapore, South Korea, and Denmark.

21 es in a conventional WEEE treatment plant in Denmark.

22 are and seen mainly in younger immigrants in Denmark.

23 portance of secondary melanoma prevention in Denmark.

24 dministrative and public health registers in Denmark.

25 rest has increased during the last decade in Denmark.

26 s in children born from 1980 through 1991 in Denmark.

27 on monovarietal white wine (var. Solaris) in Denmark.

28 dividual data from 6 nationwide registers in Denmark.

29 reatment of in situ and invasive melanoma in Denmark.

30 contrast to other modern societies, such as Denmark.

31 cts aged 18-60 y at 2 centers in Germany and Denmark.

32 e Copenhagen School Health Records Register, Denmark.

33 all individuals with permanent residence in Denmark.

34 ecies, with evidence of a recent increase in Denmark.

35 based cohort study was conducted in Northern Denmark.

36 ping of stocks and flows of NdFeB magnets in Denmark.

37 th registry covering the whole population of Denmark.

38 an mummies and a Bronze Age hair sample from Denmark.

39 ed hypospadias cases and 5,486 controls from Denmark.

40 mercury exposure in studies from Canada and Denmark.

41 h HIV treated at Aarhus University Hospital, Denmark.

42 at the Department of Ophthalmology, Aarhus, Denmark.

43 n 56 residences of nonsmokers in Copenhagen, Denmark.

44 nal Committee on Biomedical Research Ethics, Denmark.

45 nter as of December 31, 2011, in Copenhagen, Denmark.

46 schemic heart disease from Holbaek Hospital, Denmark.

47 2009 and ALS mortality from 1970 to 2009 in Denmark.

48 be more widespread in Great Britain than in Denmark.

49 y, the United Kingdom, Ireland, Hungary, and Denmark.

50 ney samples from Finland, Sweden, Norway and Denmark.

51 ndiagnosed COPD in the general population in Denmark.

52 ality among patients with prostate cancer in Denmark.

53 ldren (n = 6090) born in 2000 in Copenhagen, Denmark.

54 e being launched in many countries including Denmark.

55 All transfusion recipients in Sweden and Denmark.

56 diagnosed between 2000 and 2012 in Northern Denmark.

57 mmon database at Rigshospitalet, Copenhagen, Denmark.

58 national data (population: 5.2 million) from Denmark.

59 enrolled participants at 2 clinical sites in Denmark.

60 tional health registers from 1977 to 2012 in Denmark.

61 inhabitants of Lombardia and 5.5 million of Denmark.

62 gned to all live births and new residents in Denmark.

63 ctions per person-year), Finland (0.07), and Denmark (0.08) and highest in Spain (0.61), followed by

64 death occurring at <45 years of age (0.21 in Denmark; 0.26 in Scotland), higher for death occurring a

65 for death occurring at 45-59 years (0.69 in Denmark; 0.69 in Scotland), and highest for death at 60+

66 , and highest for death at 60+years (0.92 in Denmark; 0.75 in Scotland).

67 on-based cohort study of all persons born in Denmark 1967 through 1997, followed up from their 15th b

68 gnancy ending in live birth or stillbirth in Denmark, 1978-2012, with follow-up through December 31,

69 d 15-44 years from administrative records in Denmark (1995-2012).

70 Nationwide register-based cohort study in Denmark, 1997-2013.

71 Nationwide register-based cohort study in Denmark, 1999-2012.

72 sing nationwide administrative registries in Denmark (2002-2011), we studied patients 30 years or old

73 among inpatients testing positive for NoV in Denmark, 2002-2010, and to study the distribution of NoV

74 oss-sectional study of incident CRC cases in Denmark (2007-2011), categorized as post-colonoscopy or

75 cidence of massive transfusion was higher in Denmark (4.5 per 10,000) than in Sweden (2.5 per 10,000)

76 wed up in a diverticular disease sample from Denmark (5,970 cases, 3,020 controls).

77 93 to 1997, 24,623 men and 27,890 women from Denmark, 50-65 y of age and free of T2D and other chroni

78 recent history of female life expectancy in Denmark, a saga of rising, stagnating, and now again ris

79 Highly peaceful countries (Denmark) also may need less ambivalence because most gro

80 It appears that in Denmark, ambient stressors as common as increasing unemp

81 0, 2014, at Bispebjerg Hospital, Copenhagen, Denmark, among 12 healthy volunteers 18 years or older.

82 (95% confidence interval [CI]: 0.55-0.78) in Denmark and 0.55 (95% CI: 0.44-0.66) in Scotland.

83 1.05 (99% confidence interval, 1.03-1.07) in Denmark and 1.01 (.98-1.05) in the United Kingdom.

84 n stabilization in asthma incidence rates in Denmark and an increase in Sweden, and a decrease in all

85 s (Capsicum var.) grown in temperate climate Denmark and determined the contents of the four major ca

86 3 population-based case-control studies from Denmark and France.

87 were obtained from the Geological Survey of Denmark and Greenland.

88 abilized for the rest of the study period in Denmark and increased in Sweden.

89 rn limit (colder and humid maritime regions; Denmark and Norway) will probably not show large changes

90 f skin and soft tissue infections (SSTIs) in Denmark and other European countries with industrial pig

91 were tested in two independent cohorts from Denmark and Scotland by assessing the areas under the re

92 729 persons diagnosed with HCV antibodies in Denmark and Scotland, respectively.

93 In Denmark and Scotland, the majority of liver death in the

94 l HCV diagnosis and mortality registers from Denmark and Scotland, we calculated the liver mortality

95 Blood donors in Denmark and Sweden between 1987 and 2012 were followed u

96 wo-hundred eighty patients from 3 centers in Denmark and Sweden were randomized to either TAVR (n=145

97 of all females aged 10 years to 44 years in Denmark and Sweden, followed up from 2006 to 2013, infor

98 ts with a primary total joint replacement in Denmark and the United Kingdom (n = 189,286; 1987-2012).

99 Gisozi, Burundi)- and high-input (Jyndevad, Denmark and Washington, United States) management sites.

100 Kingdom, 507 AAA cases and 199 controls from Denmark, and 885 AAA cases and 1000 controls from New Ze

101 as increased in Hungary, Romania, Japan, and Denmark, and AD mortality has increased in Romania and J

102 Postlicensure studies in Australia, Denmark, and Canada have demonstrated vaccine effectiven

103 all girls in the birth cohorts 1989-1999 in Denmark, and information about HPV vaccination was obtai

104 Netherlands, Switzerland, Belgium, Portugal, Denmark, and Ireland.

105 lected from three Nordic countries (Finland, Denmark, and Norway).

106 in the UK, Poland, Germany, Canada, the USA, Denmark, and Spain.

107 erse samples from the United States, Canada, Denmark, and The Netherlands (n = 6,271), we show that i

108 centres in Canada, the Netherlands, Germany, Denmark, and the UK), we assessed the effect of IONIS-AP

109 n three of the five countries studied-India, Denmark, and the USA) showed sales restrictions were fol

110 010 of 17,525 residents of northern Jutland, Denmark, and was linked with National Danish registers o

111 e general pattern was similar for Sweden and Denmark, and we believe that similar patterns may be fou

112 rch Council of Psychiatry, Capital Region of Denmark; and the Strategic Research Grant from Health Sc

113 In Denmark, antithrombotic drug use was associated with hig

114 In Denmark approximately 10 000 groin hernias are repaired

115 hin Region Zealand and the Capital Region of Denmark (April 2015-August 2016).

116 e aged 16 years or older, and were living in Denmark at the time of study inclusion.

117 tory bowel diseases at tertiary hospitals in Denmark, Australia, and New Zealand from March 2012 thro

118 herlands, Belgium, France, Germany, Austria, Denmark, Australia, and New Zealand).

119 s (n = 157,449) and the unemployment rate in Denmark beginning in January 1995 and ending in December

120 spective cohort study involving all women in Denmark between 15 and 49 years of age who had not had c

121 g a first-time diagnosis of heart failure in Denmark between 1995 and 2012.

122 g all individuals aged 15-94 years living in Denmark between 1995 and 2014.

123 udy that included all incident SSRI users in Denmark between 1997 and 2012, the authors compared peop

124 verified upper urinary tract cancer cases in Denmark between 2000 and 2012 from the Danish Cancer Reg

125 In Denmark between 2001 and 2010, an increase in survival f

126 IV Cohort Study who had received HIV care in Denmark between Jan 1, 1995, and June 1, 2014.

127 All children (about 1.5 million) born in Denmark between January 1, 1980, and December 31, 2004,

128 lion individuals 15 years or older living in Denmark between January 1, 1980, and December 31, 2011,

129 non-therapeutic antibiotic use was banned in Denmark, bla(CTX-M) levels declined in M soils, suggesti

130 based registries, we identified all girls in Denmark born during 1985-1999, for whom information on H

131 icide mortality reported a fall in deaths in Denmark, but there were also decreases in suicide deaths

132 in independent case-control sample sets from Denmark (cases diagnosed 1983-2010), Sweden (cases diagn

133 tients with CHC with or without cirrhosis in Denmark compared with the general population.

134 rectal cancer in Sweden, Spain, Germany, and Denmark completed the LARS score questionnaire, includin

135 ion, The Spastics Society and Vanforefonden (Denmark); Cooperativa Sociale "Gli Anni in Tasca" and Fo

136 e UK (London, Birmingham, and Edinburgh) and Denmark (Copenhagen) were studied.

137 2 decades, the incidence of heart failure in Denmark declined among older individuals (>50 years), bu

138 udy based on nationwide data from Sweden and Denmark describes the complete range of massive transfus

139 and the widespread use of routine imaging in Denmark did not translate into better survival.

140 collected medical data from all hospitals in Denmark during 1980 to 2009.

141 ntervention at suicide prevention clinics in Denmark during 1992-2010 were compared with people who d

142 dy included 9908 patients undergoing RYGB in Denmark during 2006 to 2010 and 99,080 matched general p

143 se, covering all HPeV infections detected in Denmark during 2009-2012 among children <5 years of age.

144 anish-born, non-Western immigrants living in Denmark during the entire follow-up period also showed a

145 ongitudinal cohort study of children born in Denmark during the period from 1980 to 2010 who were ali

146 n for infertility at Frederiksberg Hospital, Denmark, during 1977-2010, and 4,712 of these men were f

147 a, Brazil, Democratic Republic of the Congo, Denmark, Egypt, France, Germany, India, Norway, and Thai

148 ferent world regions (China, Czech Republic, Denmark, England, Iran, Japan, Malawi, Mexico, South Kor

149 from Paris, France; DF, Mexico; Copenhagen, Denmark; England, UK; and Barcelona, Spain.

150 ed in independent replications in Brazil and Denmark, ensuring reliability of the data.

151 ase 2a trial in 25 secondary care centres in Denmark, Estonia, France, Germany, Italy, Latvia, Lithua

152 all countries with increasing OPC incidence (Denmark, Estonia, France, the Netherlands, Poland, Slova

153 rom the INTERPHONE Study (Australia, Canada, Denmark, Finland, France, Germany, Israel, Italy, Japan,

154 nd Sri Lanka), and 11 high-income countries (Denmark, Finland, Germany, Greece, Hungary, Ireland, Jap

155 91) within the population-based registers of Denmark, Finland, Norway, and Sweden.

156 included those who had not been residents in Denmark for at least 1 year before VTE diagnosis, patien

157 f nasal filters (Rhinix; Rhinix ApS, Aarhus, Denmark) for the prevention of symptoms related to seaso

158 cases and 2,723 controls from 3 PD studies (Denmark, France) that obtained information on smoking th

159 We used country-specific data from Denmark, France, Germany, Italy, Poland, and the United

160 ould likely be cost effective at 30 years in Denmark, France, Germany, Italy, Poland, and the United

161 ntries (the USA, Australia, Belgium, Canada, Denmark, France, Germany, Sweden, and the UK).

162 utions throughout Europe (in Czech Republic, Denmark, France, Greece, Italy, Netherlands, Sweden, and

163 tres in Argentina, Brazil, Bulgaria, Canada, Denmark, France, Hungary, Italy, Mexico, Romania, and th

164 gist, and pathologist, from seven countries (Denmark, France, Italy, Japan, Netherlands, Portugal, an

165 A total of 3768943 individuals born in Denmark from 1955 to 2012 were followed up during the st

166 is cohort study included all persons born in Denmark from 1968 to 2008 (n = 2,789,807) and in Sweden

167 ildren (<18 years of age) treated for CHD in Denmark from 1977 to 2015, their need for reintervention

168 mosomal abnormalities lasting >/=20 weeks in Denmark from 1978 to 2011 (n= 1 972 857), we identified

169 egister-based analysis of BJ-tuberculosis in Denmark from 1994 to 2011.

170 performed a population-based cohort study in Denmark from 1995 through 2012 (cumulative population, 7

171 d time trends in AS hospitalization rates in Denmark from 1995 through 2012.

172 cohort study of all singleton live births in Denmark from 1996 through 2005 (626,875 births), with fo

173 records covering all hospital encounters in Denmark from 1996 to 2014.

174 rate transfusions in Sweden from 1987 and in Denmark from 1996.

175 (of whom, 5,197 (11%) used azathioprine) in Denmark from 1997 to 2008.

176 Children born in Denmark from 1997 to 2011 or born in Sweden from 2006 to

177 All live-born singletons in Denmark from 1998 to 2007 were identified.

178 women with early breast cancer diagnosed in Denmark from 1998 to 2011.

179 previous comorbidity admitted for syncope in Denmark from 2001 to 2009 were identified in nationwide

180 ion on all hospital admissions for stroke in Denmark from 2003 to 2012, and the Danish Registry of Ca

181 All ICUs in Denmark from 2005 to 2013.

182 A total of 2 894 688 persons born in Denmark from January 1, 1955, through December 31, 2006,

183 nts included 139 patients with primary CM in Denmark from January 1, 1960, to December 31, 2012.

184 ding all individuals (n = 1 741 271) born in Denmark from January 1, 1980, through December 31, 2007,

185 ed cases of in situ and invasive melanoma in Denmark from January 1, 1985, through December 31, 2012.

186 ng all elective incisional hernia repairs in Denmark from January 1, 2007, to December 31, 2010.

187 cohort study including all children born in Denmark from January 1997 through December 2012.

188 mprising all live-born singleton children in Denmark from pregnancies overlapping the A(H1N1) influen

189 ated with BEP at Rigshospitalet, Copenhagen, Denmark, from 1984 to 2007, were included.

190 of Microbiology, Odense University Hospital, Denmark, from 1995 through 2014.

191 he A(H1N1) influenza vaccination campaign in Denmark, from November 2, 2009, to March 31, 2010.

192 Based on a population-based study in Denmark, genetic factors appear to contribute to develop

193 tions in 5 countries (China, Czech Republic, Denmark, Germany, and the United States).

194 in 13 countries (Australia, Belgium, Canada, Denmark, Germany, Hungary, Israel, the Netherlands, New

195 3 cancer centres in five European countries (Denmark, Germany, Italy, Switzerland, and the UK) and ra

196 ary intervention centres in Belgium, Brazil, Denmark, Germany, Singapore, Spain, Switzerland, and the

197 udy was a multicentre trial done in Belgium, Denmark, Germany, the Netherlands, Sweden, the UK, and t

198 Since 1992, Denmark has documented the largest outbreak of tuberculo

199 k & Co, Kenilworth, NJ/ALK-Abello, Horsholm, Denmark) has demonstrated beneficial effects on allergic

200 referred to give birth at Hvidovre Hospital, Denmark, have been offered participation in the prospect

201 Conclusions and Relevance: In Denmark, having a child with a major congenital anomaly

202 By record-linking the Western Denmark Heart Registry and the Danish National Patient R

203 Mustard and Senning operations in Sweden and Denmark identified all operated TGA patients.

204 lar disorder, or unipolar depression born in Denmark in 1955 or later from linked nationwide register

205 cohort containing 11640 individuals born in Denmark in 1955 or later with their first recorded MDD d

206 a for women who delivered live singletons in Denmark in 1978-2008 (almost 1.4 million pregnancies).

207 Laboratory of Mycobacteriology, Copenhagen, Denmark in 2002-2011.

208 Early administration of BCG-Denmark in LW infants is associated with major reduction

209 Data on all ELAPEs and APEs performed in Denmark in the period January 1, 2009, through August 20

210 ial sponsor) HDM SLIT-tablet (ALK, Horsholm, Denmark) in adults and adolescents with HDM respiratory

211 irst Aarhus Immunotherapy Symposium (Aarhus, Denmark) in December 2015 by leading clinicians, scienti

212 (Phleum pratense 75 000 SQ-T/2800 BAU, ALK, Denmark), in mono- and polysensitized subjects.

213 ent Optimmunize meeting, held in Copenhagen, Denmark, in August 2012.

214 The master dataset contains all residents of Denmark (including Greenland) who had a positive chlamyd

215 based study of national health registries in Denmark, including all individuals (n = 1 741 271) born

216 013, we randomized LW neonates to "early BCG-Denmark" (intervention group; n = 2083) or "control" (lo

217 es of restrictions in five countries- India, Denmark, Ireland, the UK and the USA).

218 tion-based cohort study from five countries (Denmark, Israel, Norway, Sweden and Western Australia) c

219 derwent major elective noncardiac surgery in Denmark (January 1, 2005, to November 30, 2011) for the

220 l clinics and private practices) in Germany, Denmark, Lithuania, Spain, and the United Kingdom.

221 e-cohort design included all persons born in Denmark (N = 1683385) between January 1, 1967, and Decem

222 re or hospital-based setting in 1997-2013 in Denmark (n = 190671) and 2000-2013 in the United Kingdom

223 rospective data sets from Finland (n = 860), Denmark (n = 453), and Scotland (n = 231).

224 nuary 1, 1980, through December 31, 1991, in Denmark (n=677915).

225 for infection during the period 1995-2011 in Denmark (N=806,835), of whom 11,343 persons had severe m

226 or "control" (local policy for LW and no BCG-Denmark; n = 2089) at discharge from the maternity ward

227 Registers, and National Patient Registers in Denmark, Norway, and Sweden.

228 o July 31, 2011, at a university hospital in Denmark of 21 patients with CMM and 21 controls matched

229 de, register-based cohort study conducted in Denmark of 6.7 million individuals aged 18 years and old

230 Population-based cohort study in Denmark of critically ill patients in 2006-2008 with fol

231 This was a cohort study, conducted in Denmark, of 33,555 five-year survivors of adolescent or

232 als among all persons who were registered in Denmark on January 1, 1995, all patients with a diagnosi

233 ETHOD: The study followed all people born in Denmark on or after Jan.

234 grass pollen season in June 2014 in Aarhus, Denmark, on 65 adults with proven grass allergy.

235 el to that of seawater in coastal waters off Denmark (Oresund) and New England, USA.

236 In Denmark, out-of-hospital cardiac arrests have been syste

237 alysis of 3 BCG trials showed that early BCG-Denmark reduced mortality by 38% (MRR, 0.62; 95% CI, .46

238 the present trial to test whether early BCG-Denmark reduces neonatal mortality by 45%.

239 2006, and December 31, 2011, in the Central Denmark Region.

240 at Aarhus University, the Region of Southern Denmark Research Foundation, and Worzner's Foundation.

241 In Denmark, risk of epilepsy was increased in children with

242 eden, Cambodia, United Kingdom, Switzerland, Denmark, Rwanda, and Namibia) were within 12% and 10% of

243 ion of pesticides alone was likely to exceed Denmark's freshwater dilution capacity in 1999-2011.

244 ve cohort study at 2 university hospitals in Denmark, screening all patients for toxigenic C difficil

245 n), histamine release test (HR) (RefLab ApS, Denmark), skin prick test (SPT) and intradermal test (ID

246 derived from preconception cohort studies in Denmark (Snart Foraeldre) and North America [PRESTO (Pre

247 domized trials in Guinea-Bissau of early BCG-Denmark (Statens Serum Institut) given to low-weight (LW

248 gene in 12% of the 118 strains isolated from Denmark, suggesting that this novel adhesin represents a

249 5 622 patients in the United States, Norway, Denmark, Sweden, and the United Kingdom, death occurred

250 l registries from the United States, Norway, Denmark, Sweden, Germany, and the United Kingdom.

251 originated from a place outside present day Denmark (the island of Bornholm excluded), and that she

252 In Denmark, the incidence of malignant melanoma (MM) has do

253 ditional 1,972 cases and 1,812 controls from Denmark, the Netherlands and Sweden, 18 genomic regions

254 from specialist referral centres in the UK, Denmark, the Netherlands, and New Zealand.

255 linics in five countries (Australia, Canada, Denmark, the Netherlands, and the UK).

256 opulation-based cohort studies in Norway and Denmark, the Norwegian Mother and Child Cohort Study (Mo

257 eral societies' guidelines and statements in Denmark, the United Kingdom, Europe, Canada, Brazil, and

258 ch Council of Psychiatry, Region of Southern Denmark; the Research Council of Psychiatry, Capital Reg

259 t cancer between 1958 and 2001 in Sweden and Denmark; the study included 963 women with major coronar

260 In Denmark there were 722 cases of incident PBC, female:mal

261 increased in Hungary, Romania, Austria, and Denmark; therefore, the mortality decline is not univers

262 nhagen University Hospital in Frederiksberg, Denmark; they had previously completed a 68-wk lifestyle

263 tes (P<0.01) and for ruptured AAA from 5% in Denmark to 52% in the United States (P<0.01).

264 , individually matched case-control study in Denmark to assess whether hospitalization for trauma is

265 This led researchers from Denmark to conduct an epidemiological study on the incid

266 rdiac arrest after nationwide initiatives in Denmark to facilitate bystander-mediated resuscitative e

267 e data on out-of-hospital cardiac arrests in Denmark to functional outcome data and reported the 1-ye

268 A fast-track pathway has been established in Denmark to investigate patients with serious nonspecific

269 m all over world gathered near Copenhagen in Denmark to participate in 'The Stem Cell Niche', part of

270 ed up in specialized hospital departments in Denmark (total population 5.7 million).

271 also conducted a meta-analysis of the 3 BCG-Denmark trials.

272 = 34,910) of live-born infants collected in Denmark (two-sided p = .023, odds ratio = 7.76 [95% conf

273 In this nationwide cohort study in Denmark, use of oral fluconazole in pregnancy was associ

274 d and investigated a listeriosis outbreak in Denmark using patient interviews and whole-genome sequen

275 The gap between female life expectancy in Denmark vs. Sweden grew to 3.5 y in the period 1975-2000

276 Denmark was among the first countries to ban the use of

277 Early administration of BCG-Denmark was associated with a nonsignificant reduction i

278 here all diagnostic M. genitalium testing in Denmark was centralized at the Statens Serum Institut.

279 referral centers in the United States and in Denmark was conducted from June 1, 2016, to March 31, 20

280 he Long Life Family Study (United States and Denmark), we constructed endophenotypes and assessed the

281 population-based prospective cohort study in Denmark, we found that asymptomatic carriers of toxigeni

282 03), a prospective study of elderly women in Denmark, we found that impaired fasting plasma glucose c

283 rements across La Rioja province (Spain) and Denmark, we investigate how various properties of forest

284 In a study of incident CRC cases in Denmark, we observed that tumors found in patients who h

285 since 1923 at Askov Experimental Station in Denmark, we quantified four broad-spectrum beta-lactam A

286 cents aged 15 to 34 years who were living in Denmark were followed up from January 1, 2000, to Decemb

287 Trainees from 4 University Hospitals in East Denmark were included (N = 54).

288 Trainees from 4 University Hospitals in East Denmark were included (N = 54).

289 mber 31, 2010, obtained residency permits in Denmark were included and matched in a 1 : 6 ratio on ag

290 l registered AEDs (2007-2011) in Copenhagen, Denmark, were identified and geocoded.

291 00 suicides per 100 000 prisoners apart from Denmark (where it was 91 per 100 000), followed by weste

292 isease was lowest in South Korea, Spain, and Denmark, where only 5-10% of men and women had more than

293 ssed a cohort that included all the women in Denmark who had a pregnancy ending between October 1, 20

294 ide prospective cohort study of all women in Denmark who had no psychiatric diagnoses, antidepressant

295 h registers was conducted of all patients in Denmark who received a diagnosis between January 1, 1994

296 We constructed cohorts of all patients in Denmark who underwent vagotomy during 1977-1995 and a ma

297 search organisations) in the Netherlands and Denmark with fasting LDL cholesterol levels between 2.5

298 ationwide study identified 18688 patients in Denmark with first-time OHCA from June 1, 2001, to Decem

299 s composed of approximately 30% of births in Denmark, with a boy-girl ratio of 51:49.

300 r, born between 1930 and 1989 in Copenhagen, Denmark, with measurements of height and weight from 7 t